KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants

Joanna Kennedy; David Goudie; Edward Blair; Kate Chandler; Shelagh Joss; Victoria McKay; Andrew Green; Ruth Armstrong; Melissa Lees; Benjamin Kamien; Bruce Hopper; Tiong Yang Tan; Patrick Yap; Zornitza Stark; Nobuhiko Okamoto; Noriko Miyake; Naomichi Matsumoto; Ellen Macnamara; Jennifer L Murphy; Elizabeth McCormick; Hakon Hakonarson; Marni J Falk; Dong Li; Patrick Blackburn; Eric Klee; Dusica Babovic-Vuksanovic; Susan Schelley; Louanne Hudgins; Sarina Kant; Bertrand Isidor; Benjamin Cogne; Kimberley Bradbury; Mark Williams; Chirag Patel; Helen Heussler; Celia Duff-Farrier; Phillis Lakeman; Ingrid Scurr; Usha Kini; Mariet Elting; Margot Reijnders; Janneke Schuurs-Hoeijmakers; Mohamed Wafik; Anne Blomhoff; Claudia AL Ruivenkamp; Esther Nibbeling; Alexander JM Dingemans; Emilie D Douine; Stanley F Nelson; Valerie A Arboleda; Ruth Newbury-Ecob

Journal article

KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants

Joanna Kennedy, David Goudie, Edward Blair, Kate Chandler, Shelagh Joss, Victoria McKay, Andrew Green, Ruth Armstrong, Melissa Lees, Benjamin Kamien, Bruce Hopper, Tiong Yang Tan, Patrick Yap, Zornitza Stark, Nobuhiko Okamoto, Noriko Miyake, Naomichi Matsumoto, Ellen Macnamara, Jennifer L Murphy, Elizabeth McCormick Show all

Genetics in Medicine | NATURE PUBLISHING GROUP | Published : 2019

DOI: 10.1038/s41436-018-0259-2

Abstract

PURPOSE: Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported. METHODS: We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review. RESULTS: We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations..

View full abstract

University of Melbourne Researchers

Tiong Yang Tan Author Paediatrics Royal Children's Hospital

Zornitza Stark Author Paediatrics Royal Children's Hospital

Grants

Awarded by Wellcome Trust

Awarded by Department of Health

Awarded by Wellcome Trust Sanger Institute

Awarded by NIH Early Independence Award

Awarded by EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT

Awarded by OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH

Funding Acknowledgements

The authors would like to acknowledge the KAT6A Foundation (http://www.kat6a.org/) and all the patients and their families who completed the survey and consented to this study. We would also like to acknowledge the DDD study. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee (REC) approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network. This study makes use of DECIPHER (http://decipher.sanger.ac.uk), which is funded by the Wellcome Trust. J.K. held an NIHR Academic Clinical Fellowship post during this course of this study. This work was also supported by an NIH Early Independence Award to V.A.A. (DP5OD024579), and the KAT6A Foundation.